Snowball logo
logo
FIXX_logo

Homology Medicines Inc

FIXX • NASDAQ Не торгуется
-- $0,00 $  (0%)
Оценка
EPS
-35,1
Рост
Чистый доход, YoY
51,06%
FCF, YoY
20,7%
Прогноз
EPS (FWD)
-0,7
Другое
Размер лота
1 шт.
О компании
Тикер
FIXX
ISIN
US4380831077
Страна
США
Сектор (GICS)
Здравоохранение
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Часто задаваемые вопросы

В каком секторе работает Homology Medicines Inc (FIXX)?

Homology Medicines Inc относится к сектору Здравоохранение.

Выплачивает ли Homology Medicines Inc (FIXX) дивиденды?

Нет, Homology Medicines Inc не выплачивает дивиденды.